Vascular Endothelial Growth Factor Increases Human Cardiac Microvascular Endothelial Cell Permeability to Low-Density Lipoproteins

Journal of Heart and Lung Transplantation

Volumn 28, Issue 9, 2009, Pages 950-957

  Wong, Brian W ^a   Rahmani, Maziar ^a   Luo, Zongshu ^a   Yanagawa, Bobby ^a   Wong, Donald ^a   Luo, Honglin ^a   McManus, Bruce M ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; RECOMBINANT VASCULOTROPIN;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; MALE; MONOLAYER CULTURE; PRIORITY JOURNAL; TUNICA MEDIA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CELL MEMBRANE PERMEABILITY; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPOPROTEINS, LDL; MALE; MICROCIRCULATION; PEPTIDE FRAGMENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 69149084456     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.05.005     Document Type: Article

References (56)

1. Wilson J.E., Wood S., McDonald P., et al. Contribution of lipids to the pathogenesis of transplant vascular sclerosis. Transplant Immunol 5 (1997) 247-502
2. McDonald P.C., Kenyon J.A., and McManus B.M. The role of lipids in transplant vascular disease. Lab Invest 78 (1998) 1187-1201
3. Choy J.C., Granville D.J., Hunt D.W., et al. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 33 (2001) 1673-1690
4. Rose M.L. Role of endothelial cells in allograft rejection. Vasc Med 2 (1997) 105-114
5. Choy J.C., Podor T.J., Yanagawa B., et al. The regulation and consequences of immune-mediated cell death in atheromatous diseases. Cardiovasc Toxicol 3 (2003) 269-282
6. Dong C., Wilson J.E., Winters G.L., et al. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 74 (1996) 921-931
7. McManus B.M., Horley K.J., Wilson J.E., et al. Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 147 (1995) 293-308
8. McManus B.M., Malcom G., Kendall T.J., et al. Lipid overload and proteoglycan expression in chronic rejection of the human transplanted heart. Clin Transplant 8 (1994) 336-340
9. Senger D.R., Perruzzi C.A., Feder J., et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46 (1986) 5629-5632
10. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983-985
11. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
12. Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309-1312
13. Lal B.K., Varma S., Pappas P.J., et al. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res 62 (2001) 252-262
14. Six I., Kureishi Y., Luo Z., et al. Akt signaling mediates VEGF/VPF vascular permeability in vivo. FEBS Lett 532 (2002) 67-69
15. Weis S., Shintani S., Weber A., et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113 (2004) 885-894
16. Chou M.T., Wang J., and Fujita D.J. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 3 (2002) 32
17. Pedram A., Razandi M., and Levin E.R. Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J Biol Chem 277 (2002) 44385-44398
18. Eliceiri B.P., Paul R., Schwartzberg P.L., et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4 (1999) 915-924
19. Paul R., Zhang Z.G., Eliceiri B.P., et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7 (2001) 222-227
20. Seymour L.W., Shoaibi M.A., Martin A., et al. Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells. Lab Invest 75 (1996) 427-437
21. Aiello L.P., Bursell S.E., Clermont A., et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46 (1997) 1473-1480
22. Breslin J.W., Pappas P.J., Cerveira J.J., et al. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am J Physiol Heart Circ Physiol 284 (2003) H92-H100
23. Claude P. Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol 39 (1978) 219-232
24. McCarthy K.M., Francis S.A., McCormack J.M., et al. Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. J Cell Sci 113 (2000) 3387-3398
25. McCarthy K.M., Skare I.B., Stankewich M.C., et al. Occludin is a functional component of the tight junction. J Cell Sci 109 (1996) 2287-2298
26. Lin H., Ignatescu M., Wilson J.E., et al. Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: geographic relationship to vessel wall proteoglycans. J Heart Lung Transplant 15 (1996) 1223-1232
27. Lin H., Wilson J.E., Roberts C.R., et al. Biglycan, decorin, and versican protein expression patterns in coronary arteriopathy of human cardiac allograft: distinctness as compared to native atherosclerosis. J Heart Lung Transplant 15 (1996) 1233-1247
28. Lai J.C., Tranfield E.M., Walker D.C., et al. Ultrastructural evidence of early endothelial damage in coronary arteries of rat cardiac allografts. J Heart Lung Transplant 22 (2003) 993-1004
29. Ment L.R., Stewart W.B., Fronc R., et al. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Brain Res Dev Brain Res 100 (1997) 52-61
30. Yokomori H., Oda M., Yoshimura K., et al. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int 23 (2003) 467-475
31. Roberts W.G., and Hasan T. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Res 53 (1993) 153-157
32. Nagy J.A., Masse E.M., Herzberg K.T., et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55 (1995) 360-368
33. Antonetti D.A., Barber A.J., Khin S., et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47 (1998) 1953-1959 Penn State Retina Research Group
34. Watanabe H., Sumi S., Urushihata T., et al. Immunohistochemical studies on vascular endothelial growth factor and platelet endothelial cell adhesion molecule-1/CD-31 in islet transplantation. Pancreas 21 (2000) 165-173
35. Aramoto H., Breslin J.W., Pappas P.J., et al. Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol 287 (2004) H1590-H1598
36. Suarez S., and Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114 (2001) 1229-1235
37. Feng D., Nagy J.A., Dvorak A.M., et al. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 59 (2000) 24-37
38. Feng D., Nagy J.A., Pyne K., et al. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem 52 (2004) 87-101
39. Dvorak A.M., and Feng D. The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle. J Histochem Cytochem 49 (2001) 419-432
40. Feng D., Nagy J.A., Hipp J., et al. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183 (1996) 1981-1986
41. Qu H., Nagy J.A., Senger D.R., et al. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the albuminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 43 (1995) 381-389
42. Gitay-Goren H., Cohen T., Tessler S., et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271 (1996) 5519-5523
43. Tessler S., Rockwell P., Hicklin D., et al. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269 (1994) 12456-12461
44. Clark E.R., and Clark E.L. Observations on changes in blood vascular endothelium in the living animal. Am J Anat 57 (1935) 385-438
45. Dejana E., Spagnuolo R., and Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86 (2001) 308-315
46. Spanel-Borowski K., and Mayerhofer A. Formation and regression of capillary sprouts in corpora lutea of immature superstimulated golden hamsters. Acta Anat (Basel) 128 (1987) 227-235
47. Ferrero E., Villa A., Ferrero M.E., et al. Tumor necrosis factor alpha-induced vascular leakage involves PECAM1 phosphorylation. Cancer Res 56 (1996) 3211-3215
48. Girnita D.M., Brooks M.M., Webber S.A., et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation 85 (2008) 1632-1639
49. Biselli P.M., Guerzoni A.R., de Godoy M.F., et al. Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 23 (2008) 371-375
50. Tambur A.R., Pamboukian S., Costanzo M.R., et al. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 690-698
51. Kim D.H., Lee N.Y., Lee M.H., et al. Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. Biol Blood Marrow Transplant 14 (2008) 1408-1416
52. Gunesacar R., Opelz G., Erken E., et al. VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol 68 (2007) 599-602
53. Lemos F.B., Mol W.M., Roodnat J.I., et al. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation 79 (2005) 1221-1225
54. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 (2002) 260-264
55. Rezai N., Corbel S.Y., Dabiri D., et al. Bone marrow-derived recipient cells in murine transplanted hearts: potential roles and the effect of immunosuppression. Lab Invest 85 (2005) 982-991
56. Rezai N., Deisher T.A., Heine H.L., et al. Effects of granulocyte-colony stimulating factor on bone marrow-derived progenitor cells in murine cardiac transplantation. Cardiovasc Pathol (2009 Jan 12) [Epub ahead of print]